-
2041
-
2042
-
2043
-
2044
Top health service concerns: a data mining study of the Shanghai health hotline
Published 2025-02-01Get full text
Article -
2045
TSH Levels in Subclinical Hypothyroidism in the 97.5th Percentile of the Population
Published 2020-01-01Get full text
Article -
2046
Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3+ CD8+ T Cells and Survival in Diffuse Large B Cell Lymphoma
Published 2020-01-01“…Herein, we identified three genetic mutations in galectin-9, a major ligand of Tim-3, in six patients with DLBCL (6/188, 3.2%) that were not detected in the COSMIC database. …”
Get full text
Article -
2047
-
2048
L-glutaminase synthesis by Klebsiella pneumoniae (AS KP 23) isolated from clinical strain, and its efficacy against human hepatocellular and breast cancer cell lines
Published 2025-02-01“…Subsequently, L-glutaminase was administered intravenously in patients with acute lymphoblastic leukemia and acute myeloid leukemia. …”
Get full text
Article -
2049
Changes in infant respiratory pathogens pre-, during, and post-COVID-19 non-pharmacological interventions in Beijing
Published 2025-01-01“…Prior to the epidemic, these rates were 11.9% (431/3611), 37.1% (160/431), and 5.0% (8/160), respectively. …”
Get full text
Article -
2050
-
2051
Respiratory pathogen spectrum and epidemiological trends in Hainan Province: a retrospective analysis from 2017 to 2023
Published 2025-02-01“…Results During 2017–2023, the number of RTI patients and pathogen detection rate was gradually decrease from 33.30% (3,886/11,670; pre-COVID-19), to 30.81% (2,034/6,602; NPI) and 22.43% (620/2,764; COVID-19). …”
Get full text
Article -
2052
Safety and efficacy of total colectomy with D3 lymph node dissection at colorectal cancer, developed at inflammatory bowel diseases (case control study)
Published 2018-08-01“…Overall 6 IBD-CRC and 18 spCRC patients were matched. IBD-CRC patients had longer operation time (313±37 vs 240±16 min, p=0.05), while there was no significant difference in mean volume of blood loss and postoperative stay duration (383±145 and 186±29 ml, p=0.24; 15.7±3.2 and 14.1±0.9 days, p=0.5 respectively). …”
Get full text
Article -
2053
-
2054
-
2055
-
2056
-
2057
-
2058
-
2059
-
2060
Neoadjuvant immunotherapy for DNA mismatch repair proficient/microsatellite stable non-metastatic rectal cancer: a systematic review and meta-analysis
Published 2025-01-01“…Non-metastatic pMMR/MSS RC patients receiving SCRT, PD-1 inhibitors, or concurrent immuno-radiotherapy in the neoadjuvant setting exhibited enhanced outcomes. …”
Get full text
Article